139 related articles for article (PubMed ID: 38603722)
1. MiR-132-3p suppresses peritoneal fibrosis induced by peritoneal dialysis via targeting TGF-β1/Smad2/3 signaling pathway.
Yin Y; Yang Y; Zhang Y; Shang Y; Li Q; Yuan J
PLoS One; 2024; 19(4):e0301540. PubMed ID: 38603722
[TBL] [Abstract][Full Text] [Related]
2. BMSC-derived Exosomes Ameliorate Peritoneal Dialysis-associated Peritoneal Fibrosis via the Mir-27a-3p/TP53 Pathway.
Zhao JL; Zhao L; Zhan QN; Liu M; Zhang T; Chu WW
Curr Med Sci; 2024 Apr; 44(2):333-345. PubMed ID: 38622424
[TBL] [Abstract][Full Text] [Related]
3. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
[TBL] [Abstract][Full Text] [Related]
4. Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats.
Ke CY; Lee CC; Lee CJ; Subeq YM; Lee RP; Hsu BG
Eur J Clin Invest; 2010 Apr; 40(4):301-9. PubMed ID: 20486991
[TBL] [Abstract][Full Text] [Related]
5. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
6. MiR-122-5p promotes peritoneal fibrosis in a rat model of peritoneal dialysis by targeting Smad5 to activate Wnt/β-catenin pathway.
Liu Y; Ma Z; Huang Z; Zou D; Li J; Feng P
Ren Fail; 2022 Dec; 44(1):191-203. PubMed ID: 35170385
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
8. miR-15a-5p suppresses peritoneal fibrosis induced by peritoneal dialysis via targeting VEGF in rats.
He Q; Wen L; Wang L; Zhang Y; Yu W; Zhang F; Zhang W; Xiao J; Wen X; Zhao Z
Ren Fail; 2020 Nov; 42(1):932-943. PubMed ID: 32909490
[TBL] [Abstract][Full Text] [Related]
9. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Hong M; Nie Z; Chen Z; Yu X; Bao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
[TBL] [Abstract][Full Text] [Related]
10. miR-128-3p inhibits high-glucose-induced peritoneal mesothelial cells fibrosis via PAK2/SyK/TGF-β1 axis.
Zhang Y; Xiao WH; Huang YX; Yang YY; Ouyang SX; Liang YM; Liu KH
Ther Apher Dial; 2023 Apr; 27(2):343-352. PubMed ID: 35900049
[TBL] [Abstract][Full Text] [Related]
11. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
[TBL] [Abstract][Full Text] [Related]
12. Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis.
Li Z; Zhang L; He W; Zhu C; Yang J; Sheng M
Int J Mol Sci; 2014 Jul; 15(7):12959-71. PubMed ID: 25054320
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of enalapril on chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Ke CY; Lin NT; Hsu BG
Chin J Physiol; 2011 Aug; 54(4):225-34. PubMed ID: 22129820
[TBL] [Abstract][Full Text] [Related]
14. MiR-200a ameliorates peritoneal fibrosis and functional deterioration in a rat model of peritoneal dialysis.
Wei X; Bao Y; Zhan X; Zhang L; Hao G; Zhou J; Chen Q
Int Urol Nephrol; 2019 May; 51(5):889-896. PubMed ID: 30888602
[TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord mesenchymal stem cells facilitate the up-regulation of miR-153-3p, whereby attenuating MGO-induced peritoneal fibrosis in rats.
Li D; Lu Z; Li X; Xu Z; Jiang J; Zheng Z; Jia J; Lin S; Yan T
J Cell Mol Med; 2018 Jul; 22(7):3452-3463. PubMed ID: 29654659
[TBL] [Abstract][Full Text] [Related]
16. Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway.
Bai Y; Wang L; TingYang ; Wang L; Ge W
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2379-2391. PubMed ID: 37052642
[TBL] [Abstract][Full Text] [Related]
17. N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway.
Mo M; Zeng Y; Zeng Y; Li S; He X; Chen X; Luo Q; Liu M; Luo C; Dou X; Peng F; Long H
Chem Biol Interact; 2023 Sep; 382():110589. PubMed ID: 37268199
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the effect of high glucose on the expression of Smad in human peritoneal mesothelial cells.
Yao Q; Qian JQ; Lin XH; Lindholm B
Int J Artif Organs; 2004 Oct; 27(10):828-34. PubMed ID: 15560676
[TBL] [Abstract][Full Text] [Related]
20. Pyrrole-imidazole polyamide targeting transforming growth factor β1 ameliorates encapsulating peritoneal sclerosis.
Serie K; Fukuda N; Nakai S; Matsuda H; Maruyama T; Murayama Y; Omata S
Perit Dial Int; 2012; 32(4):462-72. PubMed ID: 22215658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
